Cargando…
A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis
Toxoplasma gondii is one of the most successful parasites due to its ability to infect a wide variety of warm-blooded animals. It is estimated that one-third of the world's population is latently infected. The generic therapy for toxoplasmosis has been a combination of antifolates such as pyrim...
Autores principales: | Rocha-Roa, Cristian, Molina, Diego, Cardona, Néstor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198644/ https://www.ncbi.nlm.nih.gov/pubmed/30386743 http://dx.doi.org/10.3389/fcimb.2018.00360 |
Ejemplares similares
-
Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection
por: Hernández-de-los-Ríos, Alejandro, et al.
Publicado: (2019) -
Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans
por: Ybañez, Rochelle Haidee D., et al.
Publicado: (2020) -
Implications of TORCH Diseases in Retinal Development—Special Focus on Congenital Toxoplasmosis
por: de Campos, Viviane Souza, et al.
Publicado: (2020) -
Enzyme-Linked Aptamer Assay (ELAA) for Detection of Toxoplasma ROP18 Protein in Human Serum
por: Vargas-Montes, Monica, et al.
Publicado: (2019) -
In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii
por: Molina, Diego A., et al.
Publicado: (2021)